Objective To compare individually tailored, based on trimestrial biological parameter
monitoring, to fixed-schedule rituximab reinfusion for remission maintenance of antineutrophil …

Background Primary immunodeficiencies (PIDs) are inherited diseases associated with a
considerable increase in susceptibility to infections. It is known that PIDs can also predispose …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recently discovered
coronavirus, is responsible for COVID-19, a newly emerged disease that has become pandemic. …

Background: Biannual rituximab infusions over 18 months effectively maintain remission
after a “standard” remission induction regimen for patients with antineutrophil cytoplasmic …

Erdheim–Chester disease (ECD) pathophysiology remains largely unknown. Its treatment is
not codified and usually disappointing. Interferon (IFN)-α therapy lacks efficacy for some life-…

Objective. Our aim was to describe patients with giant cell arteritis (GCA)–related stroke and
to compare them with a control group of GCA patients without stroke. Methods. We created a …

Purpose The purpose of our study was to assess the concordance of aortic CT angiography
(CTA) and FDG-PET/CT in the detection of large-vessel involvement at diagnosis in patients …

Objective Intravenous immunoglobulin (IVIG) represents a therapeutic alternative in
antineutrophil cytoplasmic antibody–associated vasculitides (AAV), but its efficacy has been …

Objective. To identify characteristics and factors associated with relapse and glucocorticoid (GC)
dependence in patients with giant cell arteritis (GCA). Methods. We retrospectively …

Recent data suggest the existence of a complement alternative pathway activation in the
pathogenesis of antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a …